Clinical Trial Update: Atomoxetine, Diurnal Profiles of Cortisol and α-amylase

View source ↗

Summary

A clinical trial update studying diurnal cortisol and salivary α-amylase patterns in ADHD patients treated with atomoxetine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Praxis für kleine und grosse Leute | Conditions: ADHD | Status: UNKNOWN